Pacific Biosciences of California (PACB) — Capital Reinvestment Ratio
Pacific Biosciences of California (PACB) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($75.36 Million) in capital expenditures ($117.00K). Check PACB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pacific Biosciences of California Capital Reinvestment Ratio (2020–2020)
This chart tracks Pacific Biosciences of California's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Pacific Biosciences of California (PACB) cash conversion ratio.
Annual Capital Reinvestment Ratio for Pacific Biosciences of California (2020–2020)
Year-by-year Capital Reinvestment Ratio for Pacific Biosciences of California from 2020 to 2020. See PACB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $19.50 Million | $1.04 Million | — |